Surgical significance of telomerase activity in noncancerous liver tissue from patients with hepatocellular carcinoma

Japanese Journal of Cancer Research

Volumn 89, Issue 7, 1998, Pages 727-732

  Kanamaru, Taichi ^a   Morita, Yasushi ^a   Itoh, Takashi ^a   Yamamoto, Masahiro ^a   Kuroda, Yoshikazu ^a   Hisatomi, Hisashi ^b  

^a KOBE UNIVERSITY   (Japan)

^b SRL INC   (Japan)

Author keywords

Hepotocellular carcinoma; Noncancerous liver tissue; Telomerase activity; TRAP

Indexed keywords

TELOMERASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER FUNCTION; LIVER PARENCHYMA; MALE; METASTASIS; PRIORITY JOURNAL;

EID: 0031713473     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1998.tb03277.x     Document Type: Article

References (22)

1. Moyzis, R. K., Buckingham, J. M., Cram, L. S., Dani, M., Deaven, L. L., Jones, M. D., Meyne, J., Ratliff, R. L. and Wu, J. R. A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc. Natl. Acad. Sci. USA, 85, 6622-6626 (1988).
2. Shay, J. and Bacchetti, S. A survey of telomerase activity in human cancer. Eur. J. Cancer, 33, 787-791 (1997).
3. Kim, N., Piatyszek, M., Prowse, K., Harley, C., West, M., Ho, P., Coviello, G., Wright, W., Weinrich, S. and Shay, J. Specific association of human telomerase activity with immortal cells and cancer. Science, 266, 2011-2015 (1994).
4. Tahara, H., Nakanishi, T., Kitamoto, M., Nakashio, R., Shay, J. W., Tahara, E., Kajiyama, G. and Ide, T. Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res., 55, 2734-2736 (1995).
5. Kojima, H., Yokosuka, O., Imazeki, F., Saisho, H. and Omata, M. Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease. Gastroenterology, 112, 493-500 (1997).
6. Kitada, T., Seki, S., Kawakita, N., Kuroki, T. and Monna, T. Telomere shortening in chronic liver diseases. Biochem. Biophys. Res. Commun., 211, 33-39 (1995).
7. Ohashi, K., Tsutsumi, M., Nakajima, Y., Kobitsu, K., Nakano, H. and Konishi, Y. Telomere changes in human hepatocellular carcinomas and hepatitis virus infected non-cancerous livers. Cancer, 77, 1747-1751 (1996).
8. Miura, N., Horikawa, I., Nishimoto, A., Ohmura, H., Ito, H., Hirohashi, S., Shay, J. W. and Oshimura, M. Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis. Cancer Genet. Cytogenet., 93, 56-62 (1997).
9. Weinberg, R. A. Oncogenes, antioncogenes, and the molecular basis of multistep carcinogenesis. Cancer Res., 49, 3713-3721 (1989).
10. Hiyama, K., Hirai, Y., Koizumi, S., Akiyama, M., Hiyama, E., Piatyszek, M. A., Shay, J. W., Ishioka, S. and Yamakido, M. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J. Immunol., 155, 3711-3715 (1995).
11. Nouso, K., Urabe, Y., Higashi, T., Nakatsukasa, H., Hino, N., Ashida, K., Kinugasa, N., Yoshida, K., Uematsu, S. and Tsuji, T. Telomerase as a tool for the differential diagnosis of human hepatocellular carcinoma. Cancer, 78, 232-236 (1996).
12. Nakashio, R., Kitamoto, M., Tahara, H., Nakanishi, T., Ide, T. and Kajiyama, G. Significance of telomerase activity in the diagnosis of small differentiated hepatocellular carcinoma. Int. J. Cancer, 74, 141-147 (1997).
13. Ohta, K., Kanamaru, T., Morita, Y., Hayashi, Y., Ito, H. and Yamamoto, M. Telomerase activity in hepatocellular carcinoma as a predictor of postoperative recurrence. J. Gastroenterol., 32, 1-6 (1997).
14. The Liver Cancer Study Group of Japan. Primary liver cancer in Japan: clinicopathologic features and results of surgical treatment. Ann. Surg., 211, 277-287 (1990).
15. Okamoto, E., Furukawa, K. and Yamanaka, M. Prognosis after hepatectomy for hepatocellular carcinoma. Surg. Ther., 73, 525-533 (1995).
16. Arii, S., Tanaka, J., Yamazoe, Y., Minematsu, S., Morino, T., Fujita, K., Maetani, S. and Tobe, T. Predictive factors for intrahepatic recurrence of hepatocellular carcinoma after partial hepatectomy. Cancer, 69, 913-919 (1992).
17. Okuda, K., Tanaka, M., Nakayama, T., Saitsu, H., Tanikawa, K., Nakashima, O. and Kojiro, M. Clinico-pathologic comparison between resected hepatocellular carcinomas (HCC) and recurrent tumors. Int. Hepatol. Commun., 1, 65-71 (1993).
18. Liver Cancer Study Group of Japan. "The General Rules for the Clinical and Pathological Study of Primary Live Cancer," 3rd Ed., pp. 1-76 (1992). Kanehara, Tokyo (in Japanese).
19. Ishak, K., Baptista, A., Bianchi, L., Callea, F., Groote, J., Gudat, F., Denk, H., Desmet, V., Korb, G., MacSween, R., Phillips, M., Portmann, B., Poulsen, H., Scheuer, P., Schmidt, M. and Thaler, H. Histological grading and staging of chronic hepatitis. J. Hepatol., 22, 696-699 (1995).
20. Hisatomi, H., Nagao, K. and Komatsu, H. Quantification of telomerase activity in human liver tissues by fluorescence-based TRAP analysis. Int. Hepatol. Commun., 7, 35-42 (1997).
21. Meyerson, M., Counter, C. M., Eaton, E. N., Ellisen, L. W., Sterner, P., Caddie, S. D., Ziaugra, L., Beijersbergen, R. L., Davidoff, M. J., Liu, Q., Bacchetti, S., Haber, D. A. and Weinberg, R. A. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell, 90, 785-795 (1997).
22. Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. M., Lingner, J., Harley, C. B. and Cech, T. R. Telomerase catalytic subunit homologs from fission yeast and human. Science, 277, 955-959 (1997).